Evidence map›Paper›PMID 41329022›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

Spatial Myeloid Landscape of Large Artery Atherosclerotic and Cardioembolic Thrombi Retrieved by Mechanical Thrombectomy.

Sugyeong Jo, Taedong Ok, Chae Min Lee, Jae Woong Jeong, Yun Ju Lee, Sung Jae Shin, Sungsoon Fang, Kyung-Yul Lee, Bo Kyung Yoon

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Spatial Myeloid Landscape of Large Artery Atherosclerotic and Cardioembolic Thrombi Retrieved by Mechanical Thrombectomy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sugyeong JoGraduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
Taedong OkDepartment of Neurology, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
Chae Min LeeGraduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jae Woong JeongInstitute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.
Yun Ju LeeDepartment of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul, Republic of Korea.
Sung Jae ShinGraduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
Sungsoon FangGraduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kyung-Yul LeeDepartment of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Bo Kyung YoonGraduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0003-3436-4665

Funding

Korea Health Industry Development Institute (KHIDI) RS-2024-00403043Ministry of Health and Welfare (MOHW) HR18C001202National Research Foundation of Korea (NRF) RS-2024-00405542
6 · The paper itself

Abstract

Cardioembolic (CE) and large artery atherosclerosis (LAA) strokes are two main causes of acute ischemic stroke (AIS), carrying a high risk of recurrence. Studies on the composition of CE and LAA thrombi have produced conflicting results, underscoring the need for further investigation into more effective treatment strategies. While myeloid cells such as neutrophils and monocytes are known to promote thrombosis in cardiovascular diseases, their specific roles in thrombosis across AIS subtypes remain unclear. We enrolled 42 AIS patients undergoing endovascular thrombectomy and retrieved their thrombi. Among 42 AIS patients undergoing endovascular thrombectomy, only thrombi and clinical data from patients with large artery atherosclerosis (LAA, n = 8) or cardioembolic (CE, n = 27) stroke were included in this study, focusing on the two major etiologic subtypes of AIS. Spatial transcriptomic profiling was performed on thrombi from a subset of these patients (LAA, n = 4; CE, n = 4) to investigate the molecular characteristics of myeloid cells. Immunohistochemistry (IHC) was conducted on thrombi from all included patients (LAA, n = 8; CE, n = 27) to quantify immune cell populations. Molecular profiling revealed distinct immunological activity between subtypes, despite the absence of statistically significant differences in immune cell abundance by IHC. LAA thrombi exhibited a profibrotic profile, with CD163+ macrophages showing upregulated TGF-β pathway. scRNA-seq analysis also revealed an enrichment of profibrotic macrophages in symptomatic atherosclerotic plaques, consistent with spatial transcriptomic findings from atherosclerotic thrombi. In contrast, CE thrombi exhibited increased neutrophil activation and NET formation, with elevated CXCR4 expression in neutrophils. Our findings suggest that the TGF-β-mediated profibrotic activity of macrophages and CXCR4-driven NET formation in neutrophils are associated with distinct patterns of immunothrombosis in LAA and CE strokes, respectively. These observations could contribute to the development of etiology-specific therapeutic strategies.

Indexed as

AtherosclerosisEmbolic StrokeIschemic StrokeMyeloid CellsThrombectomyThrombosisAgedAged, 80 and overFemaleHumansMacrophagesMaleMiddle AgedNeutrophilsReceptors, CXCR4Receptors, CXCR4etiologyischemic strokespatial transcriptomicsthrombectomythrombi

Identifiers

PMID41329022
PMCPMC12671477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.